List of Excipients in API naltrexone hydrochloride and bupropion hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing naltrexone hydrochloride and bupropion hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| PD-Rx Pharmaceuticals Inc | CONTRAVE | naltrexone hydrochloride and bupropion hydrochloride | 43063-772 | ANHYDROUS LACTOSE | 2024-04-21 |
| PD-Rx Pharmaceuticals Inc | CONTRAVE | naltrexone hydrochloride and bupropion hydrochloride | 43063-772 | CELLULOSE, MICROCRYSTALLINE | 2024-04-21 |
| PD-Rx Pharmaceuticals Inc | CONTRAVE | naltrexone hydrochloride and bupropion hydrochloride | 43063-772 | CROSPOVIDONE | 2024-04-21 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for naltrexone hydrochloride and bupropion hydrochloride
Excipient focus: ANHYDROUS LACTOSE
naltrexone hydrochloride and bupropion hydrochloride drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | naltrexone hydrochloride and bupropion hydrochloride | 43063-772 |
| Nalpropion Pharmaceuticals LLC | naltrexone hydrochloride and bupropion hydrochloride | 51267-890 |
| >Company | >Ingredient | >NDC |
naltrexone hydrochloride and bupropion hydrochloride drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
naltrexone hydrochloride and bupropion hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | naltrexone hydrochloride and bupropion hydrochloride | 43063-772 |
| Nalpropion Pharmaceuticals LLC | naltrexone hydrochloride and bupropion hydrochloride | 51267-890 |
| >Company | >Ingredient | >NDC |
naltrexone hydrochloride and bupropion hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
naltrexone hydrochloride and bupropion hydrochloride drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | naltrexone hydrochloride and bupropion hydrochloride | 43063-772 |
| Nalpropion Pharmaceuticals LLC | naltrexone hydrochloride and bupropion hydrochloride | 51267-890 |
| >Company | >Ingredient | >NDC |
naltrexone hydrochloride and bupropion hydrochloride drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CYSTEINE HYDROCHLORIDE
naltrexone hydrochloride and bupropion hydrochloride drug variants containing CYSTEINE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | naltrexone hydrochloride and bupropion hydrochloride | 43063-772 |
| Nalpropion Pharmaceuticals LLC | naltrexone hydrochloride and bupropion hydrochloride | 51267-890 |
| >Company | >Ingredient | >NDC |
naltrexone hydrochloride and bupropion hydrochloride drug variants not containing CYSTEINE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
naltrexone hydrochloride and bupropion hydrochloride drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | naltrexone hydrochloride and bupropion hydrochloride | 43063-772 |
| Nalpropion Pharmaceuticals LLC | naltrexone hydrochloride and bupropion hydrochloride | 51267-890 |
| >Company | >Ingredient | >NDC |
naltrexone hydrochloride and bupropion hydrochloride drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
naltrexone hydrochloride and bupropion hydrochloride drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | naltrexone hydrochloride and bupropion hydrochloride | 43063-772 |
| Nalpropion Pharmaceuticals LLC | naltrexone hydrochloride and bupropion hydrochloride | 51267-890 |
| >Company | >Ingredient | >NDC |
naltrexone hydrochloride and bupropion hydrochloride drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
naltrexone hydrochloride and bupropion hydrochloride drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | naltrexone hydrochloride and bupropion hydrochloride | 43063-772 |
| Nalpropion Pharmaceuticals LLC | naltrexone hydrochloride and bupropion hydrochloride | 51267-890 |
| >Company | >Ingredient | >NDC |
naltrexone hydrochloride and bupropion hydrochloride drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
naltrexone hydrochloride and bupropion hydrochloride drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | naltrexone hydrochloride and bupropion hydrochloride | 43063-772 |
| Nalpropion Pharmaceuticals LLC | naltrexone hydrochloride and bupropion hydrochloride | 51267-890 |
| >Company | >Ingredient | >NDC |
naltrexone hydrochloride and bupropion hydrochloride drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
naltrexone hydrochloride and bupropion hydrochloride drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | naltrexone hydrochloride and bupropion hydrochloride | 43063-772 |
| Nalpropion Pharmaceuticals LLC | naltrexone hydrochloride and bupropion hydrochloride | 51267-890 |
| >Company | >Ingredient | >NDC |
naltrexone hydrochloride and bupropion hydrochloride drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
naltrexone hydrochloride and bupropion hydrochloride drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | naltrexone hydrochloride and bupropion hydrochloride | 43063-772 |
| Nalpropion Pharmaceuticals LLC | naltrexone hydrochloride and bupropion hydrochloride | 51267-890 |
| >Company | >Ingredient | >NDC |
naltrexone hydrochloride and bupropion hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
naltrexone hydrochloride and bupropion hydrochloride drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | naltrexone hydrochloride and bupropion hydrochloride | 43063-772 |
| Nalpropion Pharmaceuticals LLC | naltrexone hydrochloride and bupropion hydrochloride | 51267-890 |
| >Company | >Ingredient | >NDC |
naltrexone hydrochloride and bupropion hydrochloride drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
